Driving clinical trial innovation forward with precision medicine
pharmaphorum
JANUARY 17, 2023
Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Drop-out rates and data collection. Digital technology and ‘frictionless’ clinical trials.
Let's personalize your content